Poland· PL-100014565

Cipronex

A ciprofloxacin product containing ciprofloxacinum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 17 of our 19 countries.

ATC J01MA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCipronexATCJ01MA02REGISTER NO.PL-100014565PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Ciprofloxacin is registered in 17 of 19 countries.

Countries holding a registration under ATC J01MA02 (ciprofloxacin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Ciprofloxacin · ATC J01MA02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ciprofloxacin costs, country by country.

Normalised to the WHO defined daily dose (1 g), the median price runs from $2.33 in Italy to $6.51 in Switzerland — a ×2.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ciprofloxacin · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$6.51
  • IT Italy$2.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Ciprofloxacinum
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
J01MA02
ATC class
Ciprofloxacin
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

1 priced
  • gtin
    05909990334964
    10 szt.
    PLN 11.9
  • gtin
    05909990308613
  • gtin
    05909990308620

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

616 interactions on record for ciprofloxacin.

Graded by severity as the source publishes them — 110 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ciprofloxacin · interactions on record

616 records

  • 110 severe
  • 266 moderate
  • 61 minor
  • 139 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe

40 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ciprofloxacin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ciprofloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ciflox, Ciloxan
  • Belgium · Ciloxan, Ciprofloxacine Ab
  • Bulgaria · Ciprofloxacin World Medicine Europe Eood, Орпикс
  • Cyprus · Cifloxacin, Ciloxan
  • Czechia · Cifloxinal, Ciloxan
  • Germany · Ciloxan, Cipro
  • Denmark · Cetraxal, Cifin
  • Estonia · Ciloxan, Ciprinol
  • Spain · Aceoto, Cetraflux
  • Finland · Cetraxal, Ciprofloxacin Fresenius Kab
  • France · Ciflox, Ciloxan
  • United Kingdom (Northern Ireland) · Cetraxal, Ciloxan
  • Greece · Aristin-C, Bivorilan
  • Croatia · Ciflox, Ciloxan
  • Hungary · Cifloxin, Cifran
  • Ireland · Cifloxager, Cifox
  • Iceland · Cetraxal, Ciprofloxacin Alvogen
  • Italy · Basemar 250 Mg, Basemar 500 Mg
  • Lithuania · Cifran, Ciloxan
  • Luxembourg · Ciloxan, Ciprofloxacin Kabi
  • Latvia · Cifran, Ciloxan
  • Malta · Aristin-C, Cifox
  • Netherlands · Cetraxal, Ciprinol
  • Norway · Cetraxal, Cilox
  • Portugal · Cetraflux, Ciplox
  • Romania · Cifran, Ciprinol
  • Sweden · Cetraxal, Ciloxan
  • Slovenia · Ciloxan, Ciprinol
  • Slovakia · Ciphin, Ciprinol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c0255d7f-a965-49ff-a645-b309af8cd5c7
GET /v1/drugs/c0255d7f-a965-49ff-a645-b309af8cd5c7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05909990308613 ¦ Rp ¦ Skasowane ¦ 2523\n10 tabl.\n05909990308620 ¦ Rp ¦ Skasowane ¦ 2524\n20 tabl.\n05909990334964 ¦ Rp ¦ 27879\n10 tabl.",
  "substance": "Ciprofloxacini hydrochloridum 582 mg",
  "common_name": "Ciprofloxacinum",
  "pl_product_id": "100014565",
  "pozwolenie_nr": "03086",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about ciprofloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.